These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4401051)

  • 41. [Optimization of hypotensive therapy in hospitals].
    Sidorenko GI; Pavlova AI; Nechesova TA; Al'khimovich VM; Gaĭduk VN
    Kardiologiia; 1985 Jan; 25(1):12-6. PubMed ID: 2858599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Felodipine versus hydrochlorothiazide as an addition to a beta-blocker in the treatment of hypertension.
    Borgmästars H; Forsén B; Tuomilehto J; Hellebø R; Walle PO; Nielsen HM; Nielsen E; Winkel O; Steiness E; Ibsen H
    Drugs; 1987; 34 Suppl 3():136-8. PubMed ID: 2894972
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of severe childhood hypertension with minoxidil: a controlled clinical study.
    Sinaiko AR; Mirkin BL
    J Pediatr; 1977 Jul; 91(1):138-42. PubMed ID: 874651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilator.
    Sannerstedt R; Brorson L; Berglund G; Werkö L
    Acta Med Scand; 1975 May; 197(5):409-14. PubMed ID: 238365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological basis for combination therapy of hypertension.
    Dolley CT
    Annu Rev Pharmacol Toxicol; 1977; 17():311-23. PubMed ID: 17355
    [No Abstract]   [Full Text] [Related]  

  • 46. Drugs in the management of hypertension. Part III.
    Page LT; Yager HM; Sidd JJ
    Am Heart J; 1976 Aug; 92(2):252-9. PubMed ID: 945939
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bases of pharmacological therapy of essential hypertension].
    Scapellato L; Stornello M
    Recenti Prog Med; 1980 Jul; 69(1):72-106. PubMed ID: 6107967
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of hypertension with obsilazin].
    Sirakova V; Penkov N; Kaponov Kh; Dimitrov G
    Vutr Boles; 1986; 25(2):32-6. PubMed ID: 2872755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practical office management of chronic hypertension.
    Raper AJ
    Va Med Mon (1918); 1974 Nov; 101(11):945-7. PubMed ID: 4428883
    [No Abstract]   [Full Text] [Related]  

  • 50. The clinical pharmacology of hypotensive vasodilator drugs.
    Zacest R
    Med J Aust; 1975 Jan; 1(SP1):4-8. PubMed ID: 235713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension].
    Löllgen H; Schmidt A; Upmeyer HJ
    Med Klin (Munich); 1986 Nov; 81(23):745-50. PubMed ID: 2880283
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravenous antihypertensive agents for patients unable to take oral medications.
    Zigmont EA; Connelly JF
    Am J Health Syst Pharm; 1995 Jul; 52(14):1514-6, 1518. PubMed ID: 7552893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Office management of hypertension.
    Grim CE
    Am Fam Physician; 1976 Jul; 14(1):91-4. PubMed ID: 937166
    [No Abstract]   [Full Text] [Related]  

  • 55. Choice of antihypertensive drugs for the treatment of hypertension, including hypertensive emergencies.
    Vidt DG
    Cardiovasc Clin; 1974; 6(2):199-221. PubMed ID: 4155351
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of malignant hypertension.
    Grim CE
    Compr Ther; 1980 May; 6(5):43-8. PubMed ID: 7379487
    [No Abstract]   [Full Text] [Related]  

  • 57. Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
    González-Gómez A; Gamio Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1983; 25(4):233-40. PubMed ID: 6139268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single and combined therapy for systemic hypertension with propranolol, hydralazine and hydrochlorothiazide: hemodynamic and neuroendocrine mechanisms of action.
    Mulvihill-Wilson J; Gaffney FA; Neal WW; Graham RM; Pettinger WA; Blomqvist CG
    Am J Cardiol; 1985 Aug; 56(4):315-20. PubMed ID: 4025172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.